ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Blood-Borne Autologous Angiogenic Cell Precursors Therapy in Patients With Critical Limb Ischemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02140931
Recruitment Status : Enrolling by invitation
First Posted : May 16, 2014
Last Update Posted : November 1, 2018
Sponsor:
Information provided by (Responsible Party):
Hemostemix

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : December 2021
  Estimated Study Completion Date : July 2022